Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma

NCT06676982 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT06676982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06676982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma
Lead sponsor
Zhejiang University
Phase
Phase 1
Overall status
Recruiting
Start date
January 10, 2025
Completion date
August 31, 2026
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced hepatocellular carcinoma